Pfizer, CytoReason extend AI pact after immune system success

Pfizer, CytoReason extend AI pact after immune system success

Source: 
Outsourcing Pharma
snippet: 

The drug company has renewed its arrangement with the artificial intelligence specialist, centered on using AI to improve understanding of the immune system.